|Closing date for invited submissions / evidence submission:||29 August 2013|
|1st appraisal committee meeting:||27 November 2013|
|2nd appraisal committee meeting||11 February 2014|
|3rd appraisal committee meeting:||12 November 2014|
|4th appraisal committee meeting:||06 May 2015|
|Associate Director:||Helen Knight|
|Technical Lead:||Pilar Pinilla-Dominguez|
|Communications manager:||Alice Law|
|Technical Advisor:||Fay McCracken|
Following the committee discussion on 12 November 2014, the decision support unit (DSU) have been commissioned to explore the estimates of the rate of spinal cord compression in people with metastatic hormone-dependent prostate cancer (and also specifically with spinal metastases from the prostate), in addition to the cost effectiveness of degarelix compared with the LHRH agonists in people with spinal metastases, if sufficient data are available. The next committee meeting for this topic will take place on Wednesday 06 May 2015.
Following the release of the appeal decision, we have been working to arrange the committee meeting discussion for this topic, which is scheduled for 12 November 2014.